Nicotinic Treatment of Post-Chemotherapy Subjective Cognitive Impairment: A Pilot Study
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Chemo Brain|Chemotherapy-related Cognitive Impairment|Chemo Fog|Breast Cancer|Chemobrain
Interventions: DRUG: Transdermal nicotine|OTHER: Placebo Transdermal Patch
Sponsor: Vanderbilt University Medical Center